美国长期护理院高血压合并与不合并痴呆居民的抗高血压治疗
研究发现认知障碍、较差躯体功能及临终/预期寿命不足6个月与使用较少抗高血压药物相关;增加抗高血压治疗强度仅与住院率小幅升高和ADL下降小幅减少相关,死亡率无显著差异。结论认为更强化抗高血压治疗未带来显著获益,在符合照护目标时可考虑减量。
要点
- 认知障碍、差躯体功能及预期寿命短者接受更少抗高血压药物。
- 每增加一种抗高血压药,住院率仅小幅升高0.24%。
- 强化治疗未显著改善死亡率,ADL下降仅小幅减少。
核心结论
- 长期护理院高血压居民未从更强化抗高血压治疗中获得显著获益。
- 在符合照护目标时,抗高血压药物是合理的减量目标。
研究设计与样本
- 观察性队列研究,覆盖全美所有长期护理院。
- 主要暴露为抗高血压治疗强度,定义为Medicare Part D配药数据中一线抗高血压药物数量。
- 结局为180天随访期间的住院、心血管住院、ADL功能下降和死亡。
主要发现
- 基线时54.4%使用1种、34.3%使用2种、11.4%使用3种及以上抗高血压药物。
- 中度或重度认知障碍与使用较少抗高血压药物相关(OR=0.80,与无或轻度障碍相比;P<.0001)。
- 较差躯体功能与使用较少抗高血压药物相关(最差三分位与最好三分位相比OR=0.64;P<.0001)。
- 临终关怀或预期寿命不足6个月与使用较少抗高血压药物相关(OR=0.80;P<.0001)。
- 每增加一种抗高血压药物,住院差异为0.24%(95%CI 0.03%-0.45%),心血管住院差异为0.30%(95%CI 0.21%-0.39%),ADL下降差异为-0.46%(95%CI -0.67%至-0.25%),死亡差异无统计学意义(-0.05%,95%CI -0.23%至0.13%)。
关键数值与推荐
- 认知障碍定义依据NH Minimum Data Set(MDS)认知功能量表的中度或重度障碍。
- 抗高血压治疗强度以Medicare Part D配药数据中一线抗高血压药物数量定义。
临床怎么用
- 对长期护理院高血压居民,尤其是认知障碍、躯体功能差或预期寿命有限者,可考虑抗高血压药物减量。
- 减量决策应与居民照护目标一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe patterns of antihypertensive medication treatment in hypertensive nursing home (NH) residents with and without dementia and determine the association between antihypertensive treatment and outcomes important to individuals with dementia. DESIGN: Observational cohort study. SETTING: All US NHs. PARTICIPANTS: Long-term NH residents treated for hypertension in the second quarter of 2013, with and without moderate or severe cognitive impairment, as defined by the NH Minimum Data Set (MDS) Cognitive Function Scale. MEASUREMENTS: The primary exposure was intensity of antihypertensive treatment, as defined as number of first-line antihypertensive medications in Medicare Part D dispensing data. The outcome measures were hospitalization, hospitalization for cardiovascular diseases using Medicare Hierarchical Condition Categories, decline in physical function using the MDS Activities of Daily Living (ADLs) scale, and death during a 180-day follow-up period. RESULTS: Of 255 670 NH residents treated for hypertension, 117 732 (46.0%) had moderate or severe cognitive impairment. At baseline, 54.4%, 34.3%, and 11.4% received one, two, and three or more antihypertensive medications, respectively. Moderate or severe cognitive impairment (odds ratio [OR] = 0.80 vs no or mild impairment; P < .0001), worse physical function (OR = 0.64 worst vs best tertile; P < .0001), and hospice or less than a 6-month life expectancy (OR = 0.80; P < .0001) were associated with receipt of fewer antihypertensive medications. Increased intensity of antihypertensive treatment was associated with small increases in hospitalization (difference per additional medication = 0.24%; 95% confidence interval = 0.03%-0.45%) and cardiovascular hospitalization (difference per additional medication = 0.30%; 95% confidence interval = 0.21%-0.39%) and a small decrease in ADL decline (difference per additional medication = -0.46%; 95% confidence interval = -0.67% to -0.25%). There was no significant difference in mortality (difference per additional medication = -0.05%; 95% confidence interval = -0.23% to 0.13%). CONCLUSION: Long-term NH residents with hypertension do not experience significant benefits from more intensive antihypertensive treatment. Antihypertensive medications are reasonable targets for deintensification in residents in whom this is consistent with goals of care. J Am Geriatr Soc 67:2058-2064, 2019.
引用
- Boockvar KS, Song W, Lee S, et al. Hypertension Treatment in US Long-Term Nursing Home Residents With and Without Dementia. J Am Geriatr Soc. 2019. PMID: 31328791. doi:10.1111/jgs.16081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。